Literature DB >> 17954563

p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.

Shannon R Payne1, Shulin Zhang, Karen Tsuchiya, Russell Moser, Kay E Gurley, Gary Longton, Johan deBoer, Christopher J Kemp.   

Abstract

p27(kip1) is a cyclin-dependent kinase inhibitor and a tumor suppressor. In some tumors, p27 suppresses tumor growth by inhibition of cell proliferation. However, this is not universally observed, implying additional mechanisms of tumor suppression by p27. p27-deficient mice are particularly susceptibility to genotoxin-induced tumors, suggesting a role for p27 in the DNA damage response. To test this hypothesis, we measured genotoxin-induced mutations and chromosome damage in p27-deficient mice. Both p27(+/-) and p27(-/-) mice displayed a higher N-ethyl-N-nitrosourea-induced mutation frequency in the colon than p27(+/+) littermates. Furthermore, cells from irradiated p27-deficient mice exhibited a higher number of chromatid breaks and showed modestly increased micronucleus formation compared to cells from wild-type littermates. To determine if this mutator phenotype was related to the cell cycle-inhibitory function of p27, we measured cell cycle arrest in response to DNA damage. Both normal and tumor cells from p27-deficient mice showed impaired G(2)/M arrest following low doses of ionizing radiation. Thus, p27 may inhibit tumor development through two mechanisms. The first is by reducing the proliferation of cells that have already sustained an oncogenic lesion. The second is by transient inhibition of cell cycle progression following genotoxic insult, thereby minimizing chromosome damage and fixation of mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954563      PMCID: PMC2223298          DOI: 10.1128/MCB.01536-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals.

Authors:  H L Erfle; D F Walsh; J Holcroft; N Hague; J G de Boer; B W Glickman
Journal:  Environ Mol Mutagen       Date:  1996       Impact factor: 3.216

2.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.

Authors:  P L Porter; K E Malone; P J Heagerty; G M Alexander; L A Gatti; E J Firpo; J R Daling; J M Roberts
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Authors:  C Catzavelos; N Bhattacharya; Y C Ung; J A Wilson; L Roncari; C Sandhu; P Shaw; H Yeger; I Morava-Protzner; L Kapusta; E Franssen; K I Pritchard; J M Slingerland
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

4.  Database and software for the analysis of mutations at the lacI gene in both transgenic rodents and bacteria.

Authors:  N F Cariello; N J Gorelick
Journal:  Environ Mol Mutagen       Date:  1996       Impact factor: 3.216

5.  A 3 milliTesla 60 Hz magnetic field is neither mutagenic nor co-mutagenic in the presence of menadione and MNU in a transgenic rat cell line.

Authors:  A Suri; J deBoer; W Kusser; B W Glickman
Journal:  Mutat Res       Date:  1996-11-11       Impact factor: 2.433

6.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

7.  A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.

Authors:  M L Fero; M Rivkin; M Tasch; P Porter; C E Carow; E Firpo; K Polyak; L H Tsai; V Broudy; R M Perlmutter; K Kaushansky; J M Roberts
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

Authors:  M V Ponce-Castañeda; M H Lee; E Latres; K Polyak; L Lacombe; K Montgomery; S Mathew; K Krauter; J Sheinfeld; J Massague
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

9.  Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.

Authors:  J A Pietenpol; S K Bohlander; Y Sato; N Papadopoulos; B Liu; C Friedman; B J Trask; J M Roberts; K W Kinzler; J D Rowley
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

10.  p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.

Authors:  H Nishino; A Knöll; V L Buettner; C S Frisk; Y Maruta; J Haavik; S S Sommer
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

View more
  25 in total

1.  The CCAAT/enhancer binding protein beta is a critical regulator of steroid-induced mitotic expansion of uterine stromal cells during decidualization.

Authors:  Wei Wang; Quanxi Li; Indrani C Bagchi; Milan K Bagchi
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 2.  The non-canonical functions of p27(Kip1) in normal and tumor biology.

Authors:  Savitha S Sharma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2016-04-15       Impact factor: 4.534

3.  p27(Kip1) controls cytokinesis via the regulation of citron kinase activation.

Authors:  Murielle P Serres; Uta Kossatz; Yong Chi; James M Roberts; Nisar P Malek; Arnaud Besson
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

4.  Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21.

Authors:  Brian J Leibowitz; Wei Qiu; Hongtao Liu; Tao Cheng; Lin Zhang; Jian Yu
Journal:  Mol Cancer Res       Date:  2011-03-30       Impact factor: 5.852

Review 5.  Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.

Authors:  Chinthalapally V Rao; Adam S Asch; Hiroshi Y Yamada
Journal:  Carcinogenesis       Date:  2016-11-12       Impact factor: 4.944

6.  Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Andrew Burgess; Andrew J Deans; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

7.  Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.

Authors:  H Liu; H Qiu; Y Song; Y Liu; H Wang; M Lu; M Deng; Y Gu; J Yin; K Luo; Z Zhang; X Jia; G Zheng; Z He
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

8.  p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage.

Authors:  Myriam Cuadrado; Paula Gutierrez-Martinez; Aneta Swat; Angel R Nebreda; Oscar Fernandez-Capetillo
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

9.  Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.

Authors:  Shinichiro Kawamoto; Katsuya Yamamoto; Masanori Toyoda; Kimikazu Yakushijin; Hiroshi Matsuoka; Hironobu Minami
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490

10.  Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas.

Authors:  W L See; J P Miller; M Squatrito; E Holland; M D Resh; A Koff
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.